After the important and enriching tour that saw the presentation of MMM at world-class trade fairs in the Med-Tech and Life Sciences fields, a new and significant stage is added that will allow the project to cross, once again, the Italian-Swiss borders.
The project partner companies Techinnova-as lead partner-and MTM will, in fact, have the opportunity to introduce MMM to the wide audience present at the next edition of IFA Next, which will be held in Berlin from September 2 to 6, 2022, at the Messegelände Berlin ExpoCenter City, the Berlin fairgrounds where numerous public and private fairs and events are organized every year.
The IFA (Internationale Funkausstellung Berlin), one of the oldest technology fairs in Germany, is now one of the largest technology fairs in the world, capable of hosting more than 1,500 exhibitors and up to 200,000 visitors each year who are passionate about products and solutions in the field of advanced technology and consumer electronics. In 2019, at the last regular edition of the fair before the pandemic, there were 1,939 exhibitors from 49 countries on a total exhibition area of about 285,000 square meters. On that occasion, there were 154,996 visitors, with 5,361 accredited journalists.
Within the traditional trade fair format, IFA Next is positioned as a new innovation platform where companies, research and development institutes, universities, start-ups and trade associations present solutions, concepts and product ideas for the markets of the future. The main themes span the following areas: 5G, IoT, artificial intelligence, robotics, Smart Living, VR & AR, future mobility, digital health and sustainability.
The event therefore proves to be the ideal setting for as many stakeholders as possible interested in the world of Medical Innovation to discover the great potential of ROG (Real Organ Generation), a highly interactive and responsive software application that enables users to perform virtual surgery simulations. The platform has been implemented within the MMM project, whose goal is to create 3D models of human tissues and organs, with a particular focus on the heart and circulatory system. In this way, the MMM project will be able to enable professionals to prepare, execute and optimize personalized surgical interventions, simultaneously addressing one of the major problems in healthcare: the early and inaccurate diagnosis of dangerous heart and other organ diseases.
The MMM R&D Team that will attend the Berlin fair is ready in order to enjoy the valuable opportunities for comparison offered by the event and to weave new relationships capable of expanding the network of potential project users.